ALC Alcon
- 79.840
- -1.130-1.40%
Alcon News
Alcon's Growth Trajectory: Positive Survey Insights and Product Launches Drive Buy Rating
Sight Sciences Says It Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump
Sight Sciences (SGHT) said Monday it has received a jury trial verdict of $34 million related to the patent-infringement case it filed in September 2021 against Alcon (ALC) in the US District Court fo
Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and Its Hydrus Microstent for Microinvasive Glaucoma Surgery
MENLO PARK, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences"), an eyecare technology company focused on developing and commercializing innovative, interventional
Eyewear Market Report 2024: Global Market Size, Trends and Competitive Analysis to 2030 Featuring EssilorLuxottica, Carl Zeiss, J&J, Bausch & Lomb, Marchon, Fielmann, Alcon, Hoya, Safilo
Alcon Inc. (VTX:ALC) Is a Favorite Amongst Institutional Investors Who Own 64%
Alcon Is Maintained at Buy by Stifel
Alcon Is Maintained at Buy by Stifel
Stifel Maintains Buy on Alcon, Maintains $95 Price Target
Stifel analyst Thomas Stephan maintains Alcon with a Buy and maintains $95 price target.
Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and Iradimed (IRMD)
Needham Sees BSX, CNMD, RMD Beating Street, Despite Medtech Slow Down
Alcon Initiated at Buy by Goldman Sachs
Alcon Initiated at Buy by Goldman Sachs
Goldman Sachs Initiates Coverage On Alcon With Buy Rating, Announces Price Target of $100
Goldman Sachs analyst Richard Felton initiates coverage on Alcon with a Buy rating and announces Price Target of $100.
Alcon To Go Ex-Dividend On May 14th, 2024 With 0.24662 USD Dividend Per Share
April 9th - $Alcon(ALC.US)$ is trading ex-dividend on May 14th, 2024. Shareholders of record on May 15th, 2024 will receive 0.24662 USD dividend per share on May 16th, 2024. The ex-dividend date i
Alcon Publishes Agenda for 2024 Annual General Meeting
Alcon (NYSE:ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on May 8, 2024.
CFRA Highlights Alcon's 'Top Position in Eye Care Market', Lifts Share PT
Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and Cabaletta Bio (CABA)
Investing in Alcon (VTX:ALC) Five Years Ago Would Have Delivered You a 29% Gain
Alcon's Medical Chief to Retire; Successor Named
Alcon (ALC.SW) appointed Terry Kim as chief medical officer, effective April, according to a Tuesday release. Kim is succeeding Stephen Lane, who is retiring after serving seven years at the Swiss eye
The Zacks Analyst Blog Highlights Booking Holdings, Mitsubishi UFJ Financial, Micron Technology, American Electric Power and Alcon
Alcon's Growth Trajectory: Buy Rating Affirmed Amidst Upcoming Product Launch and Market Share Expansion
Here's Why We Think Alcon (VTX:ALC) Might Deserve Your Attention Today
Analysis
Price Target
No Data
